Aviv Efrat
Analyst · Jefferies. Please go ahead
Thank you, Art. For the quarter ended September 30, 2016, the recurring net investment income totaled $0.17 per share. In addition, we had $0.02 per share of other income and $0.02 per share from the fee waiver. As a result, net investment income for the quarter was $0.21 per share. Looking at some of the expense categories, management fees after waiver totaled $7.9 million. General and administrative expenses totaled $1.8 million, and interest expense totaled $7 million. During the quarter ended September 30, unrealized gain from investment was $23 million, or $0.32 per share, primarily due to the IPO of of J.A. Cosmetics health. We also had unrealized loss from our various debt instruments of $12 million, or $0.16 per share. We had about $2 million, or $0.02 per share of realized gains. Excess dividend over net income was $5 million, or $0.07 per share. Consequently, entity per share went up $0.11 from $8.94 to $9.05 per share. As a reminder, our entire portfolio, credit facility and senior notes are mark-to-market by our Board of Directors each quarter using the exit price provided by independent valuation firms, securities exchanges, or independent broker dealer quote when active markets are available under ASC 820 and 825. In case of where broker dealer quotes are inactive, we use independent valuation firms to value the investment. Our overall debt portfolio has a weighted average yield of 11.9%. On September 30, our portfolio consisted of 56 companies across 27 different industries. The portfolio was invested in 35% in senior secured debt, 37% in second lien secured debt, 15% in subordinated debt, and 13% in preferred and common equity. 79% of the portfolio had a floating rate, including 72% with a floor and average LIBOR floor was 1.2%. Now, let me call – turn the call back to Art.